Tomoyuki Kawamata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomoyuki Kawamata has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Tadashi Tanioku
Department of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, Wakayama, Japan
3 shared publicationsYasuyuki Tokinaga
Anesthesiology, Wakayama Medical University, Wakayama, JPN
3 shared publicationsHiroaki Hemmi
Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University School of Medicine, Wakayama 641-8509, Japan
2 shared publicationsKeisuke Fujii
Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan
2 shared publications- Tadashi Tanioku
Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan
2 shared publications Tomoyuki Maruyama
Department of Anesthesiology, Wakayama Medical University School of Medicine, Wakayama, Japan
2 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by Springer Nature in Journal of Anesthesia
- p. 1-11
Transmembrane protein 45b in peripheral sensory neurons selectively mediates IL-31-dependent chemical itch
Purpose We previously identified transmembrane protein 45b (Tmem45b) as a pain-related molecule essential for mechanical pain hypersensitivity but not for thermal pain hypersensitivity. A subset of Tmem45b is expressed in TRPV1-positive primary afferents, which are specialized in transmitting thermal pain and specific types of itch. Here, we examined the involvement of Tmem45b in itch perception. Methods Behavioral experiments using Tmem45b knockout mice and wild-type mice were conducted to assess the role of Tmem45b in acute and chronic itch mediated by TRPV1-positive primary afferents. In addition, histochemical analyses were performed to identify Tmem45b-positive neurons in itch transmission. Results Acute itch induced by interleukin (IL)-31 and compound 48/80 was significantly attenuated in Tmem45b knockout (KO) mice compared with wild-type (WT) mice, whereas acute itch induced by histamine, the protease-activated receptor-2 activating peptide SLIGRL-NH2, and chloroquine remained unchanged. Similarly, chronic itch models induced by 2.4-dinitrofluorobenzene and imiquimod showed no significant differences between KO and WT mice. Histochemical analysis revealed that approximately 70% of dorsal root ganglion neurons that were double positive for Tmem45b mRNA and TRPV1 also expressed IL-31 receptor mRNA. Additionally, approximately 30% of dorsal root ganglion neurons that were double positive for Tmem45b mRNA and TRPV1 were also positive for natriuretic polypeptide B mRNA, a marker of pruriceptive afferents, suggesting their involvement in itch transmission. Conclusion These findings demonstrate that Tmem45b is selectively involved in IL-31-induced chemical itch and suggest that Tmem45b could serve as a novel modulator for IL-31-induced itch.
- 28 April 2026
- Published by Springer Nature in Journal of Anesthesia
- p. 1-11
Open AccessTransmembrane protein 45b in peripheral sensory neurons selectively mediates IL-31-dependent chemical itch
Purpose We previously identified transmembrane protein 45b (Tmem45b) as a pain-related molecule essential for mechanical pain hypersensitivity but not for thermal pain hypersensitivity. A subset of Tmem45b is expressed in TRPV1-positive primary afferents, which are specialized in transmitting thermal pain and specific types of itch. Here, we examined the involvement of Tmem45b in itch perception. Methods Behavioral experiments using Tmem45b knockout mice and wild-type mice were conducted to assess the role of Tmem45b in acute and chronic itch mediated by TRPV1-positive primary afferents. In addition, histochemical analyses were performed to identify Tmem45b-positive neurons in itch transmission. Results Acute itch induced by interleukin (IL)-31 and compound 48/80 was significantly attenuated in Tmem45b knockout (KO) mice compared with wild-type (WT) mice, whereas acute itch induced by histamine, the protease-activated receptor-2 activating peptide SLIGRL-NH2, and chloroquine remained unchanged. Similarly, chronic itch models induced by 2.4-dinitrofluorobenzene and imiquimod showed no significant differences between KO and WT mice. Histochemical analysis revealed that approximately 70% of dorsal root ganglion neurons that were double positive for Tmem45b mRNA and TRPV1 also expressed IL-31 receptor mRNA. Additionally, approximately 30% of dorsal root ganglion neurons that were double positive for Tmem45b mRNA and TRPV1 were also positive for natriuretic polypeptide B mRNA, a marker of pruriceptive afferents, suggesting their involvement in itch transmission. Conclusion These findings demonstrate that Tmem45b is selectively involved in IL-31-induced chemical itch and suggest that Tmem45b could serve as a novel modulator for IL-31-induced itch.
- 1 September 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (6) , 821-827
Lower extremity pain and/or numbness after laparoscopic surgery and robot-assisted surgery in the lithotomy position combined with the Trendelenburg position
Purpose The purpose of this study was to investigate the incidence and risk factors of lower extremity pain and/or numbness after laparoscopic colorectal surgery and robot-assisted laparoscopic radical prostatectomy in the lithotomy position combined with the Trendelenburg position. The relationship between creatine kinase (CK) levels and lower extremity pain and/or numbness was also investigated. Methods We retrospectively reviewed adult patients who underwent laparoscopic colorectal surgery and robot-assisted laparoscopic radical prostatectomy in the lithotomy position combined with the Trendelenburg position between May 2015 and April 2020. Logistic regression analysis was used to identify risk factors of lower extremity pain and/or numbness. Preoperative and postoperative CK levels were compared in patients with and those without lower extremity pain and/or numbness. Results Among 940 patients, 1.9% experienced lower extremity pain and/or numbness postoperatively. The incidences of lower extremity pain and/or numbness after laparoscopic colorectal surgery and after robot-assisted laparoscopic radical prostatectomy were 1.7% and 2.1%, respectively. Multivariate logistic regression analysis revealed that only duration of surgery > 4 h (odds ratio = 3.144, 95% CI: 1.102–8.969, p = 0.032) was a significant predictor of lower extremity pain and/or numbness. Postoperative median CK level in patients with lower extremity pain and/or numbness was significantly higher than that in patients without lower extremity pain and/or numbness. Conclusion The incidence of lower extremity pain and/or numbness after laparoscopic colorectal surgery was comparable to that after robot-assisted laparoscopic radical prostatectomy. Prolonged duration of surgery contributed to lower extremity pain and/or numbness. Significantly elevated CK levels in patients with lower extremity pain and/or numbness suggest the involvement of muscle injury in these symptoms.
- 1 September 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (6) , 821-827
Lower extremity pain and/or numbness after laparoscopic surgery and robot-assisted surgery in the lithotomy position combined with the Trendelenburg position
Purpose The purpose of this study was to investigate the incidence and risk factors of lower extremity pain and/or numbness after laparoscopic colorectal surgery and robot-assisted laparoscopic radical prostatectomy in the lithotomy position combined with the Trendelenburg position. The relationship between creatine kinase (CK) levels and lower extremity pain and/or numbness was also investigated. Methods We retrospectively reviewed adult patients who underwent laparoscopic colorectal surgery and robot-assisted laparoscopic radical prostatectomy in the lithotomy position combined with the Trendelenburg position between May 2015 and April 2020. Logistic regression analysis was used to identify risk factors of lower extremity pain and/or numbness. Preoperative and postoperative CK levels were compared in patients with and those without lower extremity pain and/or numbness. Results Among 940 patients, 1.9% experienced lower extremity pain and/or numbness postoperatively. The incidences of lower extremity pain and/or numbness after laparoscopic colorectal surgery and after robot-assisted laparoscopic radical prostatectomy were 1.7% and 2.1%, respectively. Multivariate logistic regression analysis revealed that only duration of surgery > 4 h (odds ratio = 3.144, 95% CI: 1.102–8.969, p = 0.032) was a significant predictor of lower extremity pain and/or numbness. Postoperative median CK level in patients with lower extremity pain and/or numbness was significantly higher than that in patients without lower extremity pain and/or numbness. Conclusion The incidence of lower extremity pain and/or numbness after laparoscopic colorectal surgery was comparable to that after robot-assisted laparoscopic radical prostatectomy. Prolonged duration of surgery contributed to lower extremity pain and/or numbness. Significantly elevated CK levels in patients with lower extremity pain and/or numbness suggest the involvement of muscle injury in these symptoms.
- 2 May 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (e3) , e971-e973
Efficacy of metyrapone for symptoms of adrenocortical carcinoma
Elevated cortisol by adrenocortical carcinoma leads to a variety of symptoms. We report on the efficacy of metyrapone in treatment of a variety of distressing symptoms caused by elevated cortisol in a patient who refused advanced treatment for adrenocortical carcinoma.
- 2 May 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (e3) , e971-e973
Efficacy of metyrapone for symptoms of adrenocortical carcinoma
Elevated cortisol by adrenocortical carcinoma leads to a variety of symptoms. We report on the efficacy of metyrapone in treatment of a variety of distressing symptoms caused by elevated cortisol in a patient who refused advanced treatment for adrenocortical carcinoma.
- Open Access
- 8 March 2023
- Published by Springer Nature in JA Clinical Reports
- Vol. 9 (1) , 1-3
Delayed-onset contact dermatitis caused by olanexidine gluconate antiseptic solution: effect of wiping off the remaining drug solution in two cases
Background: Olanexidine glucuronide (Olanedine®), an antiseptic solution may cause skin dermatitis around one week after disinfection. Although removal after the procedure is recommended to avoid skin dermatitis, whether it is effective for preventing skin dermatitis has not been documented in detail in the literature. Case presentation: We encountered two cases of delayed-onset contact dermatitis by Olanedine®. In both cases, the patient’s back was disinfected with Olanedine® and was covered with a surgical drape for epidural catheterization. After catheterization and removal of the surgical drape, the insertion site of the catheter was covered with a film dressing, then the epidural catheter was taped to the back. On the third postoperative day, the epidural catheter was removed. On the seventh postoperative day, the patients reported pruritus on the back, where an erythematous papule rash was observed. However, it was not observed at the site covered by the tape to secure the epidural catheter or by the tape of the surgical drape. Symptoms were relieved with oral or topical steroids by the time of discharge. Conclusion: Wiping off the remaining Olanedine® even a few days after disinfection may be helpful not only for reducing symptoms but also for preventing the development of contact dermatitis.
- 8 March 2023
- Published by Springer Nature in JA Clinical Reports
- Vol. 9 (1) , 1-3
Open AccessDelayed-onset contact dermatitis caused by olanexidine gluconate antiseptic solution: effect of wiping off the remaining drug solution in two cases
Background: Olanexidine glucuronide (Olanedine®), an antiseptic solution may cause skin dermatitis around one week after disinfection. Although removal after the procedure is recommended to avoid skin dermatitis, whether it is effective for preventing skin dermatitis has not been documented in detail in the literature. Case presentation: We encountered two cases of delayed-onset contact dermatitis by Olanedine®. In both cases, the patient’s back was disinfected with Olanedine® and was covered with a surgical drape for epidural catheterization. After catheterization and removal of the surgical drape, the insertion site of the catheter was covered with a film dressing, then the epidural catheter was taped to the back. On the third postoperative day, the epidural catheter was removed. On the seventh postoperative day, the patients reported pruritus on the back, where an erythematous papule rash was observed. However, it was not observed at the site covered by the tape to secure the epidural catheter or by the tape of the surgical drape. Symptoms were relieved with oral or topical steroids by the time of discharge. Conclusion: Wiping off the remaining Olanedine® even a few days after disinfection may be helpful not only for reducing symptoms but also for preventing the development of contact dermatitis.
- Open Access
- 2 November 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (45)
Tmem45b is essential for inflammation- and tissue injury–induced mechanical pain hypersensitivity
Persistent mechanical pain hypersensitivity associated with peripheral inflammation, surgery, trauma, and nerve injury impairs patients’ quality of life and daily activity. However, the molecular mechanism and treatment are not yet fully understood. Herein, we show that chemical ablation of isolectin B4-binding (IB4 + ) afferents by IB4–saporin injection into sciatic nerves completely and selectively inhibited inflammation- and tissue injury–induced mechanical pain hypersensitivity while thermal and mechanical pain hypersensitivities were normal following nerve injury. To determine the molecular mechanism involving the specific types of mechanical pain hypersensitivity, we compared gene expression profiles between IB4 + neuron-ablated and control dorsal root ganglion (DRG) neurons. We identified Tmem45b as one of 12 candidate genes that were specific to somatosensory ganglia and down-regulated by IB4 + neuronal ablation. Indeed, Tmem45b was expressed predominantly in IB4 + DRG neurons, where it was selectively localized in the trans Golgi apparatus of DRG neurons but not detectable in the peripheral and central branches of DRG axons. Tmem45b expression was barely detected in the spinal cord and brain. Although Tmem45b-knockout mice showed normal responses to noxious heat and noxious mechanical stimuli under normal conditions, mechanical pain hypersensitivity was selectively impaired after inflammation and tissue incision, reproducing the pain phenotype of IB4 + sensory neuron-ablated mice. Furthermore, acute knockdown by intrathecal injection of Tmem45b small interfering RNA, either before or after inflammation induction, successfully reduced mechanical pain hypersensitivity. Thus, our study demonstrates that Tmem45b is essential for inflammation- and tissue injury–induced mechanical pain hypersensitivity and highlights Tmem45b as a therapeutic target for future treatment.
- 2 November 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (45)
Open AccessTmem45b is essential for inflammation- and tissue injury–induced mechanical pain hypersensitivity
Persistent mechanical pain hypersensitivity associated with peripheral inflammation, surgery, trauma, and nerve injury impairs patients’ quality of life and daily activity. However, the molecular mechanism and treatment are not yet fully understood. Herein, we show that chemical ablation of isolectin B4-binding (IB4 + ) afferents by IB4–saporin injection into sciatic nerves completely and selectively inhibited inflammation- and tissue injury–induced mechanical pain hypersensitivity while thermal and mechanical pain hypersensitivities were normal following nerve injury. To determine the molecular mechanism involving the specific types of mechanical pain hypersensitivity, we compared gene expression profiles between IB4 + neuron-ablated and control dorsal root ganglion (DRG) neurons. We identified Tmem45b as one of 12 candidate genes that were specific to somatosensory ganglia and down-regulated by IB4 + neuronal ablation. Indeed, Tmem45b was expressed predominantly in IB4 + DRG neurons, where it was selectively localized in the trans Golgi apparatus of DRG neurons but not detectable in the peripheral and central branches of DRG axons. Tmem45b expression was barely detected in the spinal cord and brain. Although Tmem45b-knockout mice showed normal responses to noxious heat and noxious mechanical stimuli under normal conditions, mechanical pain hypersensitivity was selectively impaired after inflammation and tissue incision, reproducing the pain phenotype of IB4 + sensory neuron-ablated mice. Furthermore, acute knockdown by intrathecal injection of Tmem45b small interfering RNA, either before or after inflammation induction, successfully reduced mechanical pain hypersensitivity. Thus, our study demonstrates that Tmem45b is essential for inflammation- and tissue injury–induced mechanical pain hypersensitivity and highlights Tmem45b as a therapeutic target for future treatment.
- Open Access
- 2 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27593
A Case of Decreased Amplitude in Motor Evoked Potentials Under Remimazolam Anesthesia
Remimazolam is a newly developed benzodiazepine derivative. Although one case report on the use of remimazolam for motor evoked potential (MEP) monitoring has been reported, there has been no report of changes in the MEP response under remimazolam anesthesia, which is associated with impairment of the corticospinal motor track. This is a case of a 54-year-old woman who was diagnosed with an extradural extramedullary tumor. The patient reported being allergic to chicken eggs. We used remimazolam instead of propofol for anesthesia management. During tumor resection, the amplitudes of MEP responses at the left quadriceps femoris, left tibialis anterior, and left abductor hallucis muscle decreased. The surgery was scaled down and the tumor was removed in a reduced size. The patient had muscle weakness immediately after surgery but eventually recovered. In this case, we could detect changes in MEP response under remimazolam anesthesia, which suggested impairment of the motor tracts during surgery.
- 2 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27593
Open AccessA Case of Decreased Amplitude in Motor Evoked Potentials Under Remimazolam Anesthesia
Remimazolam is a newly developed benzodiazepine derivative. Although one case report on the use of remimazolam for motor evoked potential (MEP) monitoring has been reported, there has been no report of changes in the MEP response under remimazolam anesthesia, which is associated with impairment of the corticospinal motor track. This is a case of a 54-year-old woman who was diagnosed with an extradural extramedullary tumor. The patient reported being allergic to chicken eggs. We used remimazolam instead of propofol for anesthesia management. During tumor resection, the amplitudes of MEP responses at the left quadriceps femoris, left tibialis anterior, and left abductor hallucis muscle decreased. The surgery was scaled down and the tumor was removed in a reduced size. The patient had muscle weakness immediately after surgery but eventually recovered. In this case, we could detect changes in MEP response under remimazolam anesthesia, which suggested impairment of the motor tracts during surgery.
- Open Access
- 7 January 2022
- Published by Springer Nature in JA Clinical Reports
- Vol. 8 (1) , 1-4
Prevention of trigeminocardiac reflex-induced severe bradycardia during cerebral aneurysm clipping surgery by topical anesthesia of the dura surface and atropine administration: a case report
Background: Trigeminocardiac reflex (TCR) by stimulation of the sensory branch of the trigeminal nerve induces transient bradycardia and hypotension. We report a case in which light mechanical stimulation to the dura mater during brain surgery induced severe bradycardia. Case presentation: A 77-year-old woman with bradycardia-tachycardia syndrome was scheduled for clipping of an unruptured left middle cerebral artery aneurysm. General anesthesia was performed with propofol, remifentanil, and rocuronium. Before starting surgery, the function of the pyramidal tract was examined by motor evoked potential. Transcranial electric stimulation for motor evoked potential induced atrial fibrillation and tachycardia. Continuous administration of landiolol was started and verapamil was used for tachycardia. During detachment of the dura mater from the bone, an electrocardiogram suddenly showed sinus arrest for 6 s. Immediately after the manipulation was interrupted, a junctional rhythm appeared. However, light touch to the dura mater induced severe bradycardia again, and atropine was therefore administered. In addition, the dura surface was anesthetized with topical lidocaine infiltration. After that, light touch-induced bradycardia was prevented. Conclusions: We experienced a case of severe bradycardia during surgery due to TCR caused by light mechanical stimulation to the dura mater. Topical anesthesia of the dura surface and atropine administration were effective for preventing TCR-induced bradycardia.
- 7 January 2022
- Published by Springer Nature in JA Clinical Reports
- Vol. 8 (1) , 1-4
Open AccessPrevention of trigeminocardiac reflex-induced severe bradycardia during cerebral aneurysm clipping surgery by topical anesthesia of the dura surface and atropine administration: a case report
Background: Trigeminocardiac reflex (TCR) by stimulation of the sensory branch of the trigeminal nerve induces transient bradycardia and hypotension. We report a case in which light mechanical stimulation to the dura mater during brain surgery induced severe bradycardia. Case presentation: A 77-year-old woman with bradycardia-tachycardia syndrome was scheduled for clipping of an unruptured left middle cerebral artery aneurysm. General anesthesia was performed with propofol, remifentanil, and rocuronium. Before starting surgery, the function of the pyramidal tract was examined by motor evoked potential. Transcranial electric stimulation for motor evoked potential induced atrial fibrillation and tachycardia. Continuous administration of landiolol was started and verapamil was used for tachycardia. During detachment of the dura mater from the bone, an electrocardiogram suddenly showed sinus arrest for 6 s. Immediately after the manipulation was interrupted, a junctional rhythm appeared. However, light touch to the dura mater induced severe bradycardia again, and atropine was therefore administered. In addition, the dura surface was anesthetized with topical lidocaine infiltration. After that, light touch-induced bradycardia was prevented. Conclusions: We experienced a case of severe bradycardia during surgery due to TCR caused by light mechanical stimulation to the dura mater. Topical anesthesia of the dura surface and atropine administration were effective for preventing TCR-induced bradycardia.
- Open Access
- 1 October 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (5) , 100952
Comparison of plasma concentrations of levobupivacaine with and without epinephrine for thoracic paravertebral block: A randomised trial
- 1 October 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (5) , 100952
Open AccessComparison of plasma concentrations of levobupivacaine with and without epinephrine for thoracic paravertebral block: A randomised trial
- Open Access
- 1 September 2021
- Published by Springer Nature in Research Square
Tmem45b is essential for inflammation and tissue injury-induced persistent mechanical hyperalgesia
Persistent mechanical hyperalgesia, associated with peripheral inflammation and tissue injury, impairs patient’s quality of life and daily activity. However, its molecular mechanism and treatment are yet to be deciphered. Herein, we report that Tmeme45b is expressed in a subset of unmyelinated primary sensory neurons and plays an essential role in inflammation and tissue injury-induced mechanical hyperalgesia. Our findings provide new insights into the mechanisms and the treatment of mechanical hyperalgesia.
- 1 September 2021
- Published by Springer Nature in Research Square
Open AccessTmem45b is essential for inflammation and tissue injury-induced persistent mechanical hyperalgesia
Persistent mechanical hyperalgesia, associated with peripheral inflammation and tissue injury, impairs patient’s quality of life and daily activity. However, its molecular mechanism and treatment are yet to be deciphered. Herein, we report that Tmeme45b is expressed in a subset of unmyelinated primary sensory neurons and plays an essential role in inflammation and tissue injury-induced mechanical hyperalgesia. Our findings provide new insights into the mechanisms and the treatment of mechanical hyperalgesia.
- Open Access
- 7 February 2021
- Published by Springer Nature in JA Clinical Reports
- Vol. 7 (1) , 1-3
Successful removal of a central venous catheter misplaced in the right subclavian artery using an intravascular stent: a case report
Background: Cannulation of a central venous catheter is sometimes associated with serious complications. When arterial cannulation occurs, attention must be given to removal of a catheter. Case presentation: A 62-year-old man was planned for emergency thoracic endovascular aortic repair. After the induction of anesthesia, a central venous catheter was unintentionally inserted into the right subclavian artery. We planned to remove the catheter. Since we considered that surgical repair would be highly invasive for the patient, we decided to remove it using a percutaneous intravascular stent. A stent was inserted through the right axillary artery. The stent was expanded immediately after the catheter was removed. Post-procedural angiography revealed no leakage from the catheter insertion site and no occlusion of the right subclavian and vertebral arteries. There were no obvious hematoma or thrombotic complications. Conclusions: A catheter that has been misplaced into the right subclavian artery was safely removed using an intravascular stent.
- 7 February 2021
- Published by Springer Nature in JA Clinical Reports
- Vol. 7 (1) , 1-3
Open AccessSuccessful removal of a central venous catheter misplaced in the right subclavian artery using an intravascular stent: a case report
Background: Cannulation of a central venous catheter is sometimes associated with serious complications. When arterial cannulation occurs, attention must be given to removal of a catheter. Case presentation: A 62-year-old man was planned for emergency thoracic endovascular aortic repair. After the induction of anesthesia, a central venous catheter was unintentionally inserted into the right subclavian artery. We planned to remove the catheter. Since we considered that surgical repair would be highly invasive for the patient, we decided to remove it using a percutaneous intravascular stent. A stent was inserted through the right axillary artery. The stent was expanded immediately after the catheter was removed. Post-procedural angiography revealed no leakage from the catheter insertion site and no occlusion of the right subclavian and vertebral arteries. There were no obvious hematoma or thrombotic complications. Conclusions: A catheter that has been misplaced into the right subclavian artery was safely removed using an intravascular stent.